Ptc Therapeutics, Inc. · NASDAQ:PTCT

Schmertzler Michael sold 25,000 Ptc Therapeutics, Inc. shares (Form 4)

Traded Aug 19 to Aug 20, 2026 · Filed Aug 21, 2026

From Aug 19 to Aug 20, 2026, Schmertzler Michael (Director) sold 25,000 Ptc Therapeutics, Inc. shares at an average US$72.22 for US$1.81M under a trading plan, leaving 1,361,594 shares. Filed Aug 21, 2026 (Form 4).

Sold
25,000 shares
Price
US$72.22 average (US$70.78 to US$73.67)
Value
US$1.81M
Holding after
1,361,594 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 19, 2026Common StockSale5,335US$72.861,381,259Indirect
Aug 19, 2026Common StockSale7,165US$73.671,374,094Indirect
Aug 20, 2026Common StockSale9,419US$70.781,364,675Indirect
Aug 20, 2026Common StockSale2,390US$71.881,362,285Indirect
Aug 20, 2026Common StockSale691US$72.921,361,594Indirect

Source

View original at SEC

Related